These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36289998)

  • 41. The immunomodulatory potential of phage therapy to treat acne: a review on bacterial lysis and immunomodulation.
    Farfán J; Gonzalez JM; Vives M
    PeerJ; 2022; 10():e13553. PubMed ID: 35910763
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bacteriophage Treatment: Critical Evaluation of Its Application on World Health Organization Priority Pathogens.
    Al-Ishaq RK; Skariah S; Büsselberg D
    Viruses; 2020 Dec; 13(1):. PubMed ID: 33396965
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Bacteriophage Therapy: Retrospective Review and Future Prospects].
    Tian EK; Wang Y; Wu ZX; Wan ZQ; Cheng W
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Mar; 52(2):170-175. PubMed ID: 33829687
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Family therapy approaches for anorexia nervosa.
    Fisher CA; Skocic S; Rutherford KA; Hetrick SE
    Cochrane Database Syst Rev; 2019 May; 5(5):CD004780. PubMed ID: 31041816
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pain management for women in labour: an overview of systematic reviews.
    Jones L; Othman M; Dowswell T; Alfirevic Z; Gates S; Newburn M; Jordan S; Lavender T; Neilson JP
    Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD009234. PubMed ID: 22419342
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phage Therapy in the Era of Multidrug Resistance in Bacteria: A Systematic Review.
    Aranaga C; Pantoja LD; Martínez EA; Falco A
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562968
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and safety of phage therapy against Salmonella enterica serovars Typhimurium and Enteritidis estimated by using a battery of in vitro tests and the Galleria mellonella animal model.
    Kosznik-Kwaśnicka K; Stasiłojć M; Grabowski Ł; Zdrojewska K; Węgrzyn G; Węgrzyn A
    Microbiol Res; 2022 Aug; 261():127052. PubMed ID: 35533436
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Safety and Tolerability of Bacteriophage Therapy for Chronic Rhinosinusitis Due to Staphylococcus aureus.
    Ooi ML; Drilling AJ; Morales S; Fong S; Moraitis S; Macias-Valle L; Vreugde S; Psaltis AJ; Wormald PJ
    JAMA Otolaryngol Head Neck Surg; 2019 Aug; 145(8):723-729. PubMed ID: 31219531
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Meta-analysis of scalp acupuncture for acute hypertensive intracerebral hemorrhage.
    Zheng GQ; Zhao ZM; Wang Y; Gu Y; Li Y; Chen XM; Fu SP; Shen J
    J Altern Complement Med; 2011 Apr; 17(4):293-9. PubMed ID: 21438797
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acupuncture for glaucoma.
    Law SK; Wang L; Li T
    Cochrane Database Syst Rev; 2020 Feb; 2(2):CD006030. PubMed ID: 32032457
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of Phage- and Bacteriocin-Based Therapies in Combatting Nosocomial MRSA Infections.
    Walsh L; Johnson CN; Hill C; Ross RP
    Front Mol Biosci; 2021; 8():654038. PubMed ID: 33996906
    [No Abstract]   [Full Text] [Related]  

  • 52. Progress and Pitfalls of Bacteriophage Therapy in Critical Care: A Concise Definitive Review.
    Valente L; Prazak J; Que YA; Cameron DR
    Crit Care Explor; 2021 Mar; 3(3):e0351. PubMed ID: 33786430
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Susceptibilities of multidrug-resistant pathogens responsible for complicated skin and soft tissue infections to standard bacteriophage cocktails].
    Gündoğdu A; Kılıç H; Ulu Kılıç A; Kutateladze M
    Mikrobiyol Bul; 2016 Apr; 50(2):215-23. PubMed ID: 27175494
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phage treatment of human infections.
    Abedon ST; Kuhl SJ; Blasdel BG; Kutter EM
    Bacteriophage; 2011 Mar; 1(2):66-85. PubMed ID: 22334863
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Closed-system drug-transfer devices plus safe handling of hazardous drugs versus safe handling alone for reducing exposure to infusional hazardous drugs in healthcare staff.
    Gurusamy KS; Best LM; Tanguay C; Lennan E; Korva M; Bussières JF
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012860. PubMed ID: 29582940
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Extracorporeal lung support technologies - bridge to recovery and bridge to lung transplantation in adult patients: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(5):1-47. PubMed ID: 23074408
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antivenom for European Vipera species envenoming.
    Lamb T; de Haro L; Lonati D; Brvar M; Eddleston M
    Clin Toxicol (Phila); 2017 Jul; 55(6):557-568. PubMed ID: 28349771
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Probiotics for people with cystic fibrosis.
    Coffey MJ; Garg M; Homaira N; Jaffe A; Ooi CY
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD012949. PubMed ID: 31962375
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.